Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Many patients on methotrexate experience significant side effects but still continue the medication.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

Metformin can cause rare severe skin reactions.

Low doses of date palm extract improve kidney function, but high doses may harm it.

Many people had severe allergic reactions to a common hair dye ingredient, causing them to seek medical care and miss work.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Gamma/delta T cells help defend skin against heavy metals.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Certain drugs may cause vitiligo, so patients should be monitored.

Dutasteride for hair loss can cause skin reactions like itchy red plaques.

Permanent makeup can cause delayed allergic reactions, but they can be managed with proper treatment.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.